 | Up a level |
Fontugne, Jacqueline; Cai, Peter Y; Alnajar, Hussein; Bhinder, Bhavneet; Park, Kyung; Ye, Huihui; Beg, Shaham; Sailer, Verena; Siddiqui, Javed; Blattner-Johnson, Mirjam; Croyle, Jaclyn A; Noorzad, Zohal; Calagua, Carla; MacDonald, Theresa Y; Axcrona, Ulrika; Bogaard, Mari; Axcrona, Karol; Scherr, Douglas S; Sanda, Martin G; Johannessen, Bjarne; ... (2022). Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci. JCI insight, 7(4) JCI Insight 10.1172/jci.insight.155309
Robinson, Brian D; Vlachostergios, Panagiotis J; Bhinder, Bhavneet; Liu, Weisi; Li, Kailyn; Moss, Tyler J; Bareja, Rohan; Park, Kyung; Tavassoli, Peyman; Cyrta, Joanna; Tagawa, Scott T; Nanus, David M; Beltran, Himisha; Molina, Ana M; Khani, Francesca; Miguel Mosquera, Juan; Xylinas, Evanguelos; Shariat, Shahrokh F; Scherr, Douglas S; Rubin, Mark A.; ... (2019). Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nature Communications, 10(1), p. 2977. Springer Nature 10.1038/s41467-019-10873-y
Shoag, Jonathan; Liu, Deli; Blattner, Mirjam; Sboner, Andrea; Park, Kyung; Deonarine, Lesa; Robinson, Brian D; Mosquera, Juan Miguel; Chen, Yu; Rubin, Mark Andrew; Barbieri, Christopher E (2018). SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. Journal of clinical investigation, 128(1), pp. 381-386. American Society for Clinical Investigation 10.1172/JCI96551
